Clinical Trial Update: Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FB-401 in children, adolescents, and adults (2 years and older) with mild to moderate atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• FB-401

Snippet

Sponsor: Forte Biosciences, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED